$5.38—
TRDA News
About
entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Leadership (9)
Kevin HealySenior Vice President of Regulatory Affairs
Sandeep BasnetHead of Information Technology
Jared CohenGeneral Counsel
Natarajan SethuramanPresident of Research & Development
Dipal DoshiChief Executive Officer & Director
Kerry RobertSenior Vice President of People
Nathan J. DowdenPresident & Chief Operating Officer
Karla MacDonaldChief Corporate Affairs Officer
Kory James WentworthChief Financial Officer & Treasurer
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers